Summary
This website provides information about a prescription medication used for the maintenance treatment of women with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The medication is indicated for patients who have had a complete or partial response to platinum-based chemotherapy. It emphasizes the importance of monitoring and managing potential side effects, including serious conditions like Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). The site also offers resources for patients, including financial assistance and support.
Based on content on zejula.com
No similar companies found
We offer API access to our data.
7 of 8 checks passed
Label
Value
Active Dates
7.8 years — Since Mar 2017
Web Hosting
Platform
E-Mail Provider
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals and Oncology
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
TXT Record
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|